Nuvectis Pharma, Inc. (NVCT)
↓ Download CSVKey ratios (FY2025)
-143.6%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Operating Income | -$27.57M | -$19.85M | -$22.90M | -$19.23M | -$12.89M | — |
| Net Income | -$26.44M | -$19.00M | -$22.26M | -$19.09M | -$12.89M | — |
| EPS (Diluted) | $-1.32 | $-1.11 | $-1.43 | $-1.51 | $-3.02 | — |
| Total Assets | $31.71M | $18.61M | $19.18M | $20.41M | $6.66M | — |
| Total Liabilities | $13.30M | $8.89M | $6.98M | $6.19M | $2.42M | — |
| Shareholders' Equity | $18.41M | $9.71M | $12.20M | $14.22M | -$11.01M | -$10.0K |
| Cash & Equivalents | $31.63M | $18.53M | $19.13M | $19.99M | $5.74M | — |
| Operating Cash Flow | -$16.01M | -$12.25M | -$15.95M | -$13.56M | -$9.50M | — |
| Shares Outstanding | 25.68M | 19.50M | 17.42M | 15.19M | 4.51M | — |
| Dividends Per Share | $0.00 | $0.00 | $0.00 | $0.00 | — | — |